Black Book Research has identified eight revenue cycle management outsourcing expenses that hospitals and health systems should count when judging whether an outsourcing deal delivers a net financial benefit.
The framework comes from an October 2026 report shared with Becker’s that is part of Black Book’s 2027 Hospital Revenue Cycle Accountability Survey Series. In the series’ renewal survey, 97% of surveyed hospital and health system leaders rated verifiable data on net financial benefit after all relevant costs as essential before approving an RCM outsourcing renewal.
Full cost to collect, including the hospital’s own retained resources, drew essential ratings from 95% of respondents. Another 73% gave the same rating to the rework burden created by the outsourced process.
Black Book said these figures reflect information priorities, not how often costs were underestimated or savings disappeared. A lower vendor invoice alone does not prove a positive net benefit, the firm added.
Here are the eight expense categories Black Book recommends hospitals review. The list is not ranked:
- Transition and onboarding: Setup, implementation and mobilization spending, measured against the approved estimate.
- Temporary parallel operations: Duplicate costs from running hospital and vendor processes side by side during the handover.
- Retained oversight staff: Hospital employees who supervise the vendor, validate its work and handle escalations.
- Interface and integration maintenance
- Additional services and change orders: Hospitals should separate authorized scope expansion from unexpected charges.
- Pass-through technology or data-access charges: These should be reconciled against contract pricing and actual use.
- Correcting or reprocessing work
- Prior-vendor exit charges: Documented costs of leaving the previous provider, which belong in the transition cost comparison.
Black Book also advises hospitals to examine data migration, staff training, temporary replacement staffing and financing costs tied to documented collection delays. It says hospitals should track timing effects separately from revenue that is permanently lost.
The survey included 207 leaders, each representing a separate contracting organization: 79 multi-hospital systems, 74 standalone acute-care hospitals with at least 100 staffed beds, 41 smaller standalone hospitals including critical access hospitals, and 13 specialty hospitals.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
